Celyad Oncology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 72,641 | 0.175% |
| Individual Insiders | 220,664 | 0.533% |
| Private Companies | 4,209,163 | 10.2% |
| General Public | 14,067,450 | 34% |
| VC/PE Firms | 22,858,654 | 55.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 22,858,654 | €22.9m | 0% | 1.72% | |||
| 4,209,163 | €4.2m | 0% | no data | |||
| 156,550 | €156.6k | 0% | no data | |||
| 72,641 | €72.6k | 0% | no data | |||
| 56,180 | €56.2k | 0% | no data | |||
| 7,300 | €7.3k | 0% | no data | |||
| 384 | €385.3 | 0% | no data | |||
| 250 | €248.6 | 0% | no data |